Academic trends

Your current location:HOME > Academic trends
British Finetech Medical Co., Ltd. to visit our company and signed a cooperation agreement
 

 

    November 29, 2016, the British Finetech Medical Co., Ltd. President John Mr. Spensley to visit our company 

and signed a cooperation agreement. The British Finetech Medical Co. Ltd. is located in Hertfordshire, 

founded in 1982, is the only company in the market to assist production after nerve injury  of  muscle, 

long-term implantable system nerve function action of the medical equipment company.  The  John 

Mr. Spensley to our company specifically on the specific issues of nerve root stimulation system  " the 

introduction of Chinese market implantable sacral and our general manager Li Bin, executive director of 

Zhang Zehua and other leaders conducted in-depth talks.

    Implantable sacral nerve root stimulation system which is specifically for long-term medical implant devices in patients with spinal cord injury, by the British Finetech Medical Co. Ltd. and Beijing Yi  Xin  Jia trading 

company in 2005 with the introduction of China, after strict testing and clinical verification, after 12 years and finally in August 2016 by the People's Republic of China food and Drug Administration (CFDA) the audit 

granted Chinese into the market, taking on China patients.

    The British Finetech Medical Ltd. CEO John Spensley said, to establish long-term cooperative relationship 

with our company, and signed on to the contract, to promote friendly cooperation and exchanges between 

the two sides, the two sides to deepen friendship and common development and common progress.

    Li Bin, general manager of our company to John Spensley a warm welcome, and sincerely hope that the two sides can strengthen cooperation in the field of nerve implant devices, mutual promotion. He said that 20 

years of reform and opening up to China, rapid economic development, we rely on the domestic resources in various government departments, all hospitals will support the rapid growth of development, will be 

committed to the benefit of the majority of patients with spinal cord injury China career.